CN104474093A - Traditional Chinese medicine for preventing and treating ovarian cancer and preparation method of traditional Chinese medicine - Google Patents
Traditional Chinese medicine for preventing and treating ovarian cancer and preparation method of traditional Chinese medicine Download PDFInfo
- Publication number
- CN104474093A CN104474093A CN201410705163.XA CN201410705163A CN104474093A CN 104474093 A CN104474093 A CN 104474093A CN 201410705163 A CN201410705163 A CN 201410705163A CN 104474093 A CN104474093 A CN 104474093A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- ovarian cancer
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for preventing and treating an ovarian cancer, and also relates to a preparation method of the medicine. The traditional Chinese medicine for preventing and treating the ovarian cancer, disclosed by the invention, is prepared from the following medicinal raw materials in parts by weight: 10-30 parts of rumex patientia, 20-30 parts of cortex phellodendri, 10-20 parts of honeysuckle, 10-30 parts of ligusticum wallichii, 10-30 parts of coptis chinensis, 10-20 parts of salviae miltiorrhizae and 5-8 parts of bighead atractylodes rhizome. The specific preparation method of the traditional Chinese medicine comprises the following steps: putting rumex patientia, the cortex phellodendri, honeysuckle, ligusticum wallichii, coptis chinensis, salviae miltiorrhizae, bighead atractylodes rhizome and water in a container according to the parts by weight; adding water till completely immersing the medicines; steaming twice at 100-120 DEG C for 1-1.5 hours; and cooling, and then filtering out herb residues. The traditional Chinese medicine has the effects of promoting blood circulation to remove blood stasis, clearing away heat and toxic materials, improving the internal environment of the organism, and improving the immunity, and effectively controlling disease development.
Description
Technical field
The present invention relates to a kind of compound Chinese medicinal preparation, be specifically related to a kind of Chinese medicine preventing and treating ovarian cancer, also relate to the preparation method of this compound preparation.
Background technology
Malignant tumor of ovary is one of common malignant tumor of female sex organ, and sickness rate is only second to cervical cancer and carcinoma of uterine body and arranges the 3rd, residence.But ovarian epithelium mortality of carcinoma accounts for the first place of all kinds of gynecological tumor, serious threat is caused to women's life.Because the fetal development of ovary, anatomic tissue and endocrine function are more complicated, early symptom is not true to type, the organization type of preoperative identification of ovarian tumor and good pernicious quite difficulty.Mainly seeing at most with epithelial cancer in malignant tumor of ovary, is secondly then malignant germ cell tumors.At present, the pathogenesis of ovarian cancer is still not yet completely clear.The traditional Chinese medical science thinks that ovarian cancer belongs to " disease addiction ", " gathering " category of the traditional Chinese medical science.The traditional Chinese medical science plays very important effect in treatment ovarian cancer process, has got good curative effect clinically.Traditional Chinese medical herbal treatment ovarian cancer both can anticancer, and it is basic to consolidate, and improve the self-resistance of patient, side effect is very little, is applicable to life-time service, and effect is effectively unique.No matter preoperative and postoperative, or the auxiliary treatment after chemotherapy, Chinese medicine curative effect all has clear and definite checking, plays the effect of Synergistic.
Technology contents
The invention provides a kind of Chinese medicine and preparation method of preventing and treating ovarian cancer, there is blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, improve organismic internal environment, improve immunity, effective symptom management development.
A kind of Chinese medicine and preparation method of preventing and treating ovarian cancer disclosed by the invention, by following raw materials by weight portion than making:
Rumex patientia Linn. 10 ~ 30 parts, Cortex Phellodendri 20 ~ 30 parts, Flos Lonicerae 10 ~ 20 parts, Rhizoma Chuanxiong 10 ~ 30 parts, Rhizoma Coptidis 10 ~ 30 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts and the Rhizoma Atractylodis Macrocephalae 5 ~ 8 parts.
The concrete preparation method of this invention, gets Rumex patientia Linn., Cortex Phellodendri, Flos Lonicerae, Rhizoma Chuanxiong, Rhizoma Coptidis, Radix Salviae Miltiorrhizae and the Rhizoma Atractylodis Macrocephalae according to above-mentioned parts by weight and is placed in container, and mix homogeneously, then submergence medicine is added water to, steam 1 ~ 1.5 hour at 100 ~ 120 DEG C again, twice, cooled and filtered medicinal residues.
Technical problem to be solved by this invention is, utilizes the theory of Chinese medical science that China is traditional, provides a kind of blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, improves organismic internal environment, improves immunity, effective symptom management development.
Detailed description of the invention
Embodiment 1
Raw material is taken by following proportioning:
Rumex patientia Linn. 30 parts, Cortex Phellodendri 30 parts, Flos Lonicerae 20 parts, Rhizoma Chuanxiong 30 parts, Rhizoma Coptidis 10 parts, Radix Salviae Miltiorrhizae 10 parts and the Rhizoma Atractylodis Macrocephalae 5 parts
Said medicine is put into container by preparation method, and mix homogeneously, then add water to submergence medicine, steam 1.5 hours twice at 100 DEG C, cooled and filtered medicinal residues.
Using method: oral, every day 3 times.
Embodiment 2
Raw material is taken by following proportioning:
Rumex patientia Linn. 20 parts, Cortex Phellodendri 30 parts, Flos Lonicerae 20 parts, Rhizoma Chuanxiong 10 parts, Rhizoma Coptidis 20 parts, Radix Salviae Miltiorrhizae 10 parts and the Rhizoma Atractylodis Macrocephalae 8 parts.
Said medicine is prevented in container by preparation method, and mix homogeneously, add water to submergence medicine, steam 1.5 hours twice at 110 DEG C, cooled and filtered medicinal residues.
Using method: oral, every day 3 times.
Implement case 3
Raw material is taken by following proportioning:
Rumex patientia Linn. 10 parts, Cortex Phellodendri 20 parts, Flos Lonicerae 20 parts, Rhizoma Chuanxiong 30 parts, Rhizoma Coptidis 30 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts and the Rhizoma Atractylodis Macrocephalae 5 parts.
Said medicine is put into container by preparation method, and mix homogeneously, add water to submergence medicine, at 120 DEG C, steam 1.5 hours once, cooled and filtered medicinal residues.
Using method: oral, every day 3 times.
Claims (3)
1. prevent and treat Chinese medicine and the preparation method of ovarian cancer, it is characterized in that, comprise following component composition: Rumex patientia Linn., Cortex Phellodendri, Flos Lonicerae, Rhizoma Chuanxiong, Rhizoma Coptidis, Radix Salviae Miltiorrhizae and the Rhizoma Atractylodis Macrocephalae.
2. the Chinese medicine preventing and treating ovarian cancer according to claim 1, is characterized in that said medicine to make decoction.
3. Chinese medicine preventing and treating ovarian cancer according to claim 1 and preparation method thereof, it is characterized in that getting Rumex patientia Linn., Cortex Phellodendri, Flos Lonicerae, Rhizoma Chuanxiong, Rhizoma Coptidis, Radix Salviae Miltiorrhizae and the Rhizoma Atractylodis Macrocephalae according to above-mentioned parts by weight is placed in container, and mix homogeneously, then submergence medicine is added water to, steam 1 ~ 1.5 hour twice at 100 ~ 120 DEG C again, cooled and filtered medicinal residues.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410705163.XA CN104474093A (en) | 2014-11-26 | 2014-11-26 | Traditional Chinese medicine for preventing and treating ovarian cancer and preparation method of traditional Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410705163.XA CN104474093A (en) | 2014-11-26 | 2014-11-26 | Traditional Chinese medicine for preventing and treating ovarian cancer and preparation method of traditional Chinese medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104474093A true CN104474093A (en) | 2015-04-01 |
Family
ID=52748794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410705163.XA Pending CN104474093A (en) | 2014-11-26 | 2014-11-26 | Traditional Chinese medicine for preventing and treating ovarian cancer and preparation method of traditional Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104474093A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105748726A (en) * | 2016-04-29 | 2016-07-13 | 陈芝维 | Chinese herb compound for treating ovarian cancer and preparation method thereof |
| CN111603458A (en) * | 2020-06-24 | 2020-09-01 | 南华大学附属第二医院 | A composition for treating ovarian cancer |
-
2014
- 2014-11-26 CN CN201410705163.XA patent/CN104474093A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105748726A (en) * | 2016-04-29 | 2016-07-13 | 陈芝维 | Chinese herb compound for treating ovarian cancer and preparation method thereof |
| CN111603458A (en) * | 2020-06-24 | 2020-09-01 | 南华大学附属第二医院 | A composition for treating ovarian cancer |
| CN111603458B (en) * | 2020-06-24 | 2022-12-16 | 南华大学附属第二医院 | A composition for treating ovarian cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102805840B (en) | Complex anti-tumor traditional Chinese medicine preparation | |
| CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN100998767A (en) | Traditional Chinese medicine for treating fracture and its preparing method | |
| CN104474093A (en) | Traditional Chinese medicine for preventing and treating ovarian cancer and preparation method of traditional Chinese medicine | |
| CN102114230A (en) | Medicament for treating psoriasis | |
| CN104043077A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
| CN101361949A (en) | Traditional Chinese medicine for treating gynaecologic emmeniopathy | |
| CN102204978B (en) | Medicinal composition for treating cancer pain and preparation thereof | |
| CN102631450B (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
| CN102284053B (en) | Foot bathing preparation for treating insomnia | |
| CN101664503A (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN104606628A (en) | Face-nourishing, beautifying and chloasma-removing traditional Chinese medicine composition | |
| CN104587414A (en) | Traditional Chinese medicinal composition for treating headache | |
| CN103638357A (en) | Traditional Chinese medicine composition for preventing and treating epidemic meningitis and preparation method thereof | |
| CN102579677A (en) | Chinese medicinal composition for treating brain glioma | |
| CN105106840A (en) | Pain-relieving inflammation-diminishing vomiting-arresting decoction | |
| CN104721545A (en) | Traditional Chinese medicine composition for treating acne | |
| CN104257798A (en) | Traditional Chinese medicine formula for treating common cold | |
| CN104189727A (en) | Traditional Chinese medicine used for treating intermenstrual sentiment abnormality | |
| CN103784656A (en) | Pharmaceutical composition for treating tumorous skin diabrosis | |
| CN103705716A (en) | Traditional Chinese medicine for curing mastitis | |
| CN102716422A (en) | Ligusticum chuanxiong hort blood-circulation-activating and pain-relieving pill | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin | |
| CN105106798A (en) | Traditional Chinese medicine composition for preventing and treating ovarian cancer and preparation method thereof | |
| CN104547246A (en) | Traditional Chinese medicine composition for treating haemorrhoids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150401 |
|
| WD01 | Invention patent application deemed withdrawn after publication |